AngioDynamics removes ablation zone estimator from NanoKnife following FDA warning, resumes U.S. shipments
SeptRx Inc.
First successful artificial lung use for a toddler staves off transplant for more than a year | Research roundup
Two-year-old Owen Stark became the first toddler successfully treated with an artificial lung, managing to avoid the need for a transplant more than a year later.
Owen arrived at St. Louis Children’s Hospital in the summer of 2010 near death from heart failure and dangerously high blood pressure in his lungs.
Access Scientific scoops up $10 million | Funding Roundup
Access Scientific Inc., makers of the Picc Wand and Power Wand IV catheters, closed a $10 million equity financing round.
Investment was led by CAC, a private equity firm, and followed by Access Scientific’s previous investors.
The company’s IV catheters are designed reduce patient discomfort by allowing blood tests to be drawn and fluids and medications to be delivered through a single device, which can last the duration of an entire hospital stay.